ApprovalTrail

Drug · DIN 02457474

ADENOSINE INJECTION

6 MG/2 ML SINGLE-USE PREFILLED SYRINGE

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since August 17, 2017; first marketed August 17, 2017.
Drug Identification Number (DIN)
02457474
Company (DIN owner)
Fresenius Kabi Canada LtdToronto, Ontario, Canada
Schedule
Prescription
Dosage form
Solution
Route
Intravenous
Therapeutic class (ATC)
Adenosine C01EB10
Class
Human
Record last updated
August 4, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
ADENOSINE3 MGML

Other DINs named ADENOSINE INJECTION